Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Metagenomi, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
MGX
Nasdaq
2834
metagenomi.co
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Metagenomi, Inc.
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
- Jan 12th, 2026 6:30 am
Trainium3 UltraServers Now Available: Enabling Customers to Train and Deploy AI Models Faster at Lower Cost
- Dec 2nd, 2025 11:30 am
Amazon Launches New AI Chip While Teasing Future Tech Collaboration With Nvidia
- Dec 2nd, 2025 10:26 am
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
- Dec 1st, 2025 5:00 am
Metagenomi to Present at Jefferies Global Healthcare Conference in London
- Nov 17th, 2025 6:00 am
Metagenomi, Ovid CEOs step aside; Cogent soars on ‘unprecedented’ stomach cancer data
- Nov 12th, 2025 3:20 am
Metagenomi to Advance Hemophilia A Gene Therapy to Clinical Trials
- Nov 11th, 2025 3:42 pm
Metagenomi (MGX) Reports Q3 Loss, Lags Revenue Estimates
- Nov 11th, 2025 3:10 pm
Metagenomi: Q3 Earnings Snapshot
- Nov 11th, 2025 2:09 pm
Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates
- Nov 11th, 2025 2:02 pm
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development
- Nov 11th, 2025 2:01 pm
Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Beat Estimates
- Nov 6th, 2025 6:50 am
Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue Estimates
- Nov 5th, 2025 3:35 pm
Promising Penny Stocks To Watch In October 2025
- Oct 22nd, 2025 12:05 pm
Metagenomi taps Amazon's custom chips to develop gene-editing tools
- Oct 22nd, 2025 8:02 am
Here's Why Metagenomi (MGX) is a Great Momentum Stock to Buy
- Oct 20th, 2025 10:00 am
September 2025's Top Penny Stocks To Consider
- Sep 23rd, 2025 12:05 pm
Analysts Have Been Trimming Their Metagenomi, Inc. (NASDAQ:MGX) Price Target After Its Latest Report
- Aug 15th, 2025 5:27 am
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates
- Aug 12th, 2025 3:40 pm
Theravance Biopharma (TBPH) Reports Q2 Loss, Tops Revenue Estimates
- Aug 12th, 2025 3:25 pm
Scroll